Overexpression of SGK1 significantly promotes cell migration and invasion in various cancers, including breast cancer (42), lung cancer (17), colon cancer (51), glioma (71), hepatoma (71), OSCC (33), prostate cancer (20), and rhabdomyosarcoma (36). Here, SGK1 is linked to breast carcinoma.